GRTS
Closed
Gritstone Oncology Inc
0.0322
+0.0129 (+66.84%)
Last Update: 27 Nov 2024 17:30:00
Yesterday: 0.0193
Day's Range: 0.0262 - 0.035
Send
sign up or login to leave a comment!
When Written:
2.795
Gritstone Oncology Inc is a clinical-stage biotechnology company that focuses on developing cancer immunotherapies. The company's approach is to use its proprietary EDGE technology to identify and target tumor-specific neoantigens, which are unique proteins found on cancer cells that can be recognized by the immune system. Gritstone's lead product candidate, GRANITE, is a personalized cancer vaccine that is designed to stimulate the patient's immune system to attack the tumor. The company is also developing SLATE, a therapy that combines the GRANITE vaccine with checkpoint inhibitors, a type of cancer immunotherapy that helps to remove the brakes on the immune system. Gritstone Oncology was founded in 2015 and is headquartered in Emeryville, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








